ArticlePakistan journal of medical sciences2025
Late-stage diagnosis and its impact on survival in Pakistani women with cervical cancer: Findings from an institutional cancer registry.
Article in Pakistan journal of medical sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: This study aimed to analyze mean age, clinicopathological characteristics, and survival rates of cervical cancer patients in Karachi, Pakistan. Methodology: A retrospective cohort study was conducted using data from the Cancer Registry at Aga Khan University Hospital (AKUH) between January 1, 2010 to December 31, 2020. Kaplan-Meier estimates were used to calculate one-, three-, and five-year survival rates. Cox proportional hazards regression was employed to identify factors associated with survival. The analysis included 310 women diagnosed with primary cervical cancer between 2010 and 2020. Results: The mean age at diagnosis was 51.3 years (SD ± 11.3), with most women (83.9%) diagnosed at an advanced stage. Kaplan-Meier survival analysis revealed an overall mean survival time of 176.3 months (SD 18.1), with one-, three-, and five- years survival rates of 86.6%, 78.5%, and 54.4%, respectively. Cox proportional hazards regression identified late-stage diagnosis (HR = 3.64, 95% CI: 1.25-10.59) and smoking history (HR = 3.37, 95% CI: 1.27-8.97) as independent predictors of poorer survival. Conclusion: The high frequency of late-stage disease and its impact on poor survival in our study highlight the critical challenge and the urgent need for targeted public health interventions. Strategies such as enhanced community awareness campaigns, the implementation of HPV vaccination, improved cervical cancer screening programs, and the promotion of timely medical consultations are essential to facilitate earlier diagnosis and improve survival outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.